These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 7831581

  • 1. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR, Chen ZX, Takahashi N.
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
    Taimi M, Chen ZX, Breitman TR.
    Oncol Res; 1998 Oct; 10(2):75-84. PubMed ID: 9666515
    [Abstract] [Full Text] [Related]

  • 3. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
    Chen Z, Wang W, Pan J, Chen L, Xue Y.
    Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
    [Abstract] [Full Text] [Related]

  • 4. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M, Breitman TR.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):432-6. PubMed ID: 9125196
    [Abstract] [Full Text] [Related]

  • 5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
    Chen ZX, Breitman TR.
    Cancer Res; 1994 Jul 01; 54(13):3494-9. PubMed ID: 8012972
    [Abstract] [Full Text] [Related]

  • 6. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS, Gallagher RE.
    Cancer Res; 1998 Dec 15; 58(24):5770-6. PubMed ID: 9865735
    [Abstract] [Full Text] [Related]

  • 7. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK, Rephaeli A, Colosimo AL, Diaz Z, Nudelman A, Levovich I, Jing Y, Waxman S, Miller WH.
    Mol Cancer Res; 2003 Oct 15; 1(12):903-12. PubMed ID: 14573791
    [Abstract] [Full Text] [Related]

  • 8. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
    Takahashi N, Breitman TR.
    Arch Biochem Biophys; 1994 Oct 15; 314(1):82-9. PubMed ID: 7944409
    [Abstract] [Full Text] [Related]

  • 9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 10. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.
    Olsson IL, Breitman TR, Gallo RC.
    Cancer Res; 1982 Oct 01; 42(10):3928-33. PubMed ID: 6286101
    [Abstract] [Full Text] [Related]

  • 11. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR, He RY.
    Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989
    [Abstract] [Full Text] [Related]

  • 12. Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid).
    Tsurumi H, Tojo A, Takahashi T, Ozawa K, Moriwaki H, Asano S, Muto Y.
    Int J Hematol; 1993 Dec 01; 59(1):9-15. PubMed ID: 8161738
    [Abstract] [Full Text] [Related]

  • 13. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature.
    Graf N, Riesinger P, Reinhard H.
    Klin Padiatr; 1995 Dec 01; 207(2):43-7. PubMed ID: 7752598
    [Abstract] [Full Text] [Related]

  • 14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N, Ishii Y, Matsuda A, Honma Y.
    Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157
    [Abstract] [Full Text] [Related]

  • 15. [Role of cytokines in differentiation therapy with retinoic acid].
    Honma Y, Nakamaki T, Tsuruoka N.
    Gan To Kagaku Ryoho; 1993 Jun 01; 20(8):1022-7. PubMed ID: 7685582
    [Abstract] [Full Text] [Related]

  • 16. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.
    Cancer Res; 2000 Apr 01; 60(7):1824-9. PubMed ID: 10766166
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid and its rearranged receptor in the treatment of acute promyelocytic leukemia.
    Miller WH, Dmitrovsky E.
    Important Adv Oncol; 1993 Apr 01; ():81-90. PubMed ID: 8389321
    [Abstract] [Full Text] [Related]

  • 18. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N, Sausville EA, Breitman TR.
    Clin Cancer Res; 1995 Jun 01; 1(6):637-42. PubMed ID: 9816026
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
    Zheng X, Chang RL, Cui XX, Kelly KA, Shih WJ, Lin Y, Strair R, Suh J, Han ZT, Rabson A, Conney AH.
    Oncol Res; 2000 Jun 01; 12(9-10):419-27. PubMed ID: 11697820
    [Abstract] [Full Text] [Related]

  • 20. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
    Kim SH, Kim TS.
    Planta Med; 2002 Oct 01; 68(10):886-90. PubMed ID: 12391550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.